Both compounds interact with the endocannabinoid method but effect the human body in basically alternative ways.A review is underway that might adjust how cannabis is assessed less than federal regulation. In August 2023, the Office of Health and fitness and Human Products and services sent its suggestions on the DEA, which has the final say.As the